Article
p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2000
Tenti P, Vesentini N, Rondo Spaudo M, Zappatore R, Migliora P, Carnevali L, Ranzani G N
Abstract excerpt
A case-control study was performed to investigate the risk of cervical cancer associated with p53 polymorphism at codon 72, encoding either arginine or proline. It has been recently suggested that the arginine isoform increases the susceptibility to invasive cervical cancer; however, data remain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
